<DOC>
	<DOC>NCT01058863</DOC>
	<brief_summary>This study is examining how well a dry powder inhaler (DPI) of albuterol medication works to help adult and adolescent subjects 12 years of age and older with persistent asthma to improve lung function.</brief_summary>
	<brief_title>A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Procaterol</mesh_term>
	<criteria>Must provide written informed consent, Be between 12 years of age and older, Male or Female, females of nonchild bearing potential or using reliable contraception Asthma for at least 6 months, FEV1 (forced expiratory volume in 1 second) between 5080% of predicted value, and reversibility greater than or equal to 15% following 180 mcg albuterol Stable low dose of Inhaled Corticosteroids Nonsmoker, 12 months smokingfree and &lt;=10pack years history Otherwise healthy Other criteria apply Pregnant Allergic to albuterol or severe milk protein allergy Must not be on another trial for 30days. Other criteria apply</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>